At a glance
ClinicalIndex Comparison RecordN/ACompleted· 179 enrolled
Drug / intervention
Conduction system pacing +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure (PhysioSync-HF)
In Brief
A clinical study evaluating Conduction system pacing and Biventricular pacing for Heart Failure and 3 related conditions. Completed, enrolled 179 participants across 14 sites.
Detailed Summary
The purpose of this study is to evaluate the efficacy and safety of conduction system pacing versus biventricular pacing in patients with chronic heart failure with reduced ejection fraction and left bundle branch block.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Left Bundle-Branch Block, Cardiac Resynchronization, Conduction System Pacing
CountriesBrazil
CollaboratorsMinistry of Health, Brazil
Timeline
N/ACompletedFinished
2023202420252026
First PostedOct 2022
Enrollment StartNov 2022
Primary CompletionJan 2025
TodayJul 2026
First PostedOct 10, 2022
Enrollment StartNov 7, 2022
Primary CompletionJan 10, 2025
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 3.7 years ago
Interventions
Conduction system pacingdevice
Pacing from the His-Purkinje system (His-bundle pacing, left bundle branch area pacing, or deep septal pacing).
Biventricular pacingdevice
Pacing from the coronary sinus and right ventricular leads.